Find a Commonwealth Resource
Quetiapine extended-release
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Quetiapine Extended-Release is a prescription medication containing 400 mg of quetiapine fumarate per tablet, designed for oral use as an atypical antipsychotic. Manufactured by Amneal Pharmaceuticals LLC under ANDA211405, this extended-release tablet is now discontinued. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Quetiapine extended-release
Access the FDA dataset for Quetiapine extended-release — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025